These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18623939)

  • 1. Clinical classification of extent of disease in cancer of the breast.
    Cutler SJ; Myers MH
    J Natl Cancer Inst; 1967 Aug; 39(2):193-207. PubMed ID: 18623939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do estimates of long-term survival tell us whether patients diagnosed with breast cancer before age 50 years are ever cured?
    Green S
    J Clin Oncol; 2004 Feb; 22(3):392-4. PubMed ID: 14691128
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
    Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
    J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
    Lukens JN; Vapiwala N; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Staging and prognosis of breast cancer].
    Fukuuchi A
    Nihon Rinsho; 2000 Apr; 58 Suppl():383-94. PubMed ID: 11026022
    [No Abstract]   [Full Text] [Related]  

  • 9. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic drainage patterns in breast cancer patients who previously underwent mantle field radiation.
    van der Ploeg IM; Russell NS; Nieweg OE; Oldenburg HS; Kroon BB; Olmos RA; Rutgers EJ
    Ann Surg Oncol; 2009 Aug; 16(8):2295-9. PubMed ID: 19452228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors in the prognosis in breast cancer].
    Ostrovtsev LD
    Khirurgiia (Mosk); 1979 Jun; (6):92-6. PubMed ID: 449246
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary breast sarcoma.
    Lum YW; Jacobs L
    Surg Clin North Am; 2008 Jun; 88(3):559-70, vi. PubMed ID: 18514698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of recurrence more than 10 years after surgery in patients with breast carcinoma.
    Takeuchi H; Muto Y; Tashiro H
    Anticancer Res; 2009 Aug; 29(8):3445-8. PubMed ID: 19661371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Better prognosis and favorable tumor stages in patients with invasive breast mammary carcinoma after introduction of the mass screening of breast cancer in Tilburg, the Netherlands].
    Groenendijk RP; Bult P; Wobbes T
    Ned Tijdschr Geneeskd; 2004 May; 148(19):961; author reply 961-2. PubMed ID: 15160564
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
    Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases.
    Syamala V; Syamala VS; Sreeja L; Raveendran PB; Vijayalekshmi RV; Sheeja VR; Santhi S; Kuttan R; Abraham EK; Ankathil R
    J Exp Ther Oncol; 2008; 7(3):227-36. PubMed ID: 19066131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.